Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Legend Biotech Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 71 | 86 | +15 |
| Shares | 26.4M | 28.3M | +1.94M (+7.3%) |
| Value | $765.9M | $1.16B | +$397.0M (+51.8%) |
New holders (26)
Institutions that held Legend Biotech Corp at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (11)
Institutions that held Legend Biotech Corp at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,639,200 | $47.6M |
| Adage Capital Partners GP, L.L.C. | 1,300,000 | $37.7M |
| Yong Rong (HK) Asset Management Ltd | 198,312 | $5.76M |
| Canada Pension Plan Investment Board | 125,900 | $3.65M |
| Price T Rowe Associates Inc | 124,229 | $3.60M |
| California Public Employees Retirement System | 43,600 | $1.26M |
| Jefferies Group LLC | 21,000 | $609.4K |
| AlphaCentric Advisors LLC | 20,000 | $580.0K |
| Atom Investors LP | 15,339 | $445.0K |
| UBS Oconnor LLC | 15,000 | $435.0K |
| Bank of Montreal | 410 | $12.0K |